Head of Material Science/Drug Product Modeling — Oral Drug Product
- Cambridge, MA
- Full-time
- Posted
Skills
Job description
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use . I further attest that all information I submit in my employment application is true to the best of my knowledge.
Job Description
ACCOUNTABILITIES
•Provides strategic and operational leadership for the Drug Product Modeling function within Oral Drug Products, establishing predictive modeling capabilities that integrate material science, formulation properties, manufacturing processes, and drug product performance to support portfolio and business objectives.
•Builds and develops a high-performing team of drug product modeling scientists and engineers who partner across Oral Drug Product, Pharmaceutical Sciences, and manufacturing organizations to advance model-informed formulation development, process understanding, scale-up, and technology transfer.
•Leads the development and implementation of predictive modeling strategies to support formulation design, material selection, process development, dosage form optimization, manufacturing scale-up, and product robustness across clinical development phases and the product lifecycle.
•Directs the application of mechanistic, physics-based, empirical, and data-driven modeling approaches to understand and predict relationships among API and excipient critical material properties, formulation composition, processing conditions, microstructure, and drug product critical quality attributes (CQAs).
•Establishes modeling strategies for amorphous solid dispersions (ASDs/SDDs), immediate-release (IR), and controlled-release (CR) oral dosage forms, addressing the distinct material, formulation, process, and performance challenges associated with each technology.
•Integrates material properties—including particle size and morphology, bulk and tapped density, porosity, surface area, flowability, compressibility, compactability, viscoelasticity, moisture sensitivity, thermal properties, and solid-state characteristics—into predictive assessments of formulation behavior and manufacturing performance.
•Leads the application of predictive modeling to pharmaceutical unit operations, including blending, granulation, roller compaction, milling, drying, spray drying, compression, coating, and controlled-release dosage form manufacturing, as appropriate to the product and process.
•Develops and implements modeling strategies to predict the impact of material attributes, formulation composition, process parameters, equipment design, and operating conditions on process performance, process robustness, scale-up, and finished product CMAs/CQAs.
•Applies predictive approaches to understand and optimize dosage form performance, including powder flow, segregation, content uniformity, granule properties, tabletability, compactability, tensile strength, porosity, disintegration, mechanical integrity, and release performance, as relevant to the dosage form.
•Leads modeling approaches for amorphous solid dispersions to understand the relationship between polymer selection, drug loading, miscibility, glass transition behavior, moisture uptake, physical stability, phase separation, crystallization risk, and downstream manufacturability.
•Establishes predictive strategies for controlled-release products to evaluate the influence of formulation composition, polymer properties, geometry, manufacturing conditions, and product microstructure on release mechanisms, release kinetics, and manufacturing sensitivity.
•Partners with formulation scientists and process development teams to use modeling to identify critical material attributes (CMAs), critical process parameters (CPPs), critical formulation variables, and their relationships to CQAs; prioritize experiments; establish appropriate operating ranges; and improve process understanding.
•Leads the use of modeling to support scale-up, technology transfer, equipment selection, process characterization, control strategy development, and manufacturing readiness from early clinical supplies through late-stage development and commercial process definition.
•Integrates modeling with material characterization, design of experiments (DoE), process analytical technology (PAT), multivariate data analysis, process simulation, and experimental process knowledge to support mechanistic understanding and evidence-based development decisions.
•Partners with analytical development, formulation development, process engineering, manufacturing, quality, regulatory affairs, and other CMC stakeholders to incorporate predictive modeling into integrated development strategies.
•Directs the preparation of scientific modeling assessments and supporting documentation for development reports, process characterization, technology transfer, control strategy justification, and regulatory submissions, as appropriate to the development phase and intended application.
•Establishes standards, governance, and best practices for model development, verification, validation, qualification, uncertainty assessment, and application within drug product development, ensuring that modeling approaches are fit for purpose and supported by appropriate experimental evidence.
•Builds organizational capability through talent development, training, resource planning, external partnerships, and continuous advancement of mechanistic, physics-based, and data-driven modeling technologies.
•Drives innovation in predictive drug product modeling to reduce development risk, improve manufacturing robustness, accelerate scale-up, minimize unnecessary experimentation, and support reliable delivery of high-quality oral drug products.
DIMENSIONS AND ASPECTS
Technical/Functional (Line) Expertise
•Deep expertise in pharmaceutical development, drug product material science, formulation engineering, manufacturing process development, and predictive modeling, with a demonstrated ability to translate material and process understanding into actionable development decisions.
•Strong understanding of relationships among API and excipient properties, formulation composition, processing conditions, microstructure, manufacturability, physical stability, and finished product CQAs.
•Demonstrated expertise in applying mechanistic, physics-based, statistical, and data-driven modeling approaches to pharmaceutical materials, formulations, unit operations, and drug product manufacturing processes.
•Expertise spanning amorphous solid dispersions, immediate-release tablets and capsules, and controlled-release oral dosage forms, including their distinct formulation, material, process, stability, and performance requirements.
•Ability to integrate material characterization, solid-state analysis, rheology, powder technology, compaction science, thermal analysis, moisture sorption, process data, and product performance measurements into predictive models.
•Demonstrated understanding of pharmaceutical unit operations, including powder blending, granulation, roller compaction, milling, drying, spray drying, tableting, coating, and modified-release manufacturing, with the ability to model their impact on intermediate and finished product quality.
•Proven ability to apply predictive modeling to identify influential material attributes and process parameters, understand interactions, define development priorities, and support risk-based process development and control strategy decisions.
•Experience using modeling to support scale-up and technology transfer across equipment configurations, batch sizes, manufacturing sites, and clinical development phases, with an understanding of model limitations and the need for experimental confirmation.
•Ability to lead complex technical programs within a global pharmaceutical development organization, aligning scientific priorities, resources, timelines, and portfolio objectives.
Leadership
•Hires, develops, trains, and mentors a high-performing team of drug product modeling scientists and engineers responsible for advancing predictive modeling capabilities across Oral Drug Products.
•Establishes a clear functional vision centered on material-property modeling, formulation and process modeling, manufacturing science, scale-up, and prediction of drug product quality and performance.
•Develops an integrated modeling strategy that complements Biopharmaceutics Predictive Modeling while maintaining clear accountability for manufacturing, material attributes, formulation, and process-related predictions.
•Influences scientific and development strategy through recognized expertise, effective cross-functional partnerships, and the ability to translate complex model outputs into actionable recommendations.
•Mobilizes and leads cross-functional teams across multiple programs, driving alignment, scientific rigor, accountability, and disciplined execution.
•Champions inclusive leadership, talent development, succession planning, and continuous capability building across mechanistic modeling, process science, and pharmaceutical engineering.
Decision-Making and Autonomy
•Operates with high autonomy and accountability in defining modeling strategies, scientific plans, resource requirements, and external partnerships within established governance.
•Makes and communicates risk-based recommendations on material selection, formulation design, process development, equipment selection, scale-up, technology transfer, and manufacturing control strategies.
•Uses predictive modeling to identify critical material and process risks, prioritize experiments, evaluate development alternatives, and inform decisions affecting product quality, manufacturability, cost, timeline, and process robustness.
•Establishes fit-for-purpose standards for model development, verification, validation, qualification, sensitivity analysis, uncertainty assessment, and experimental confirmation.
•Evaluates when mechanistic understanding is sufficient to support a prediction and when additional experimental work, model refinement, or process characterization is required before making development or manufacturing decisions.
•Anticipates modeling capability needs across the portfolio and initiates actions to address scientific, technical, resourcing, and execution gaps.
Interaction
•Partners with PharmSci function heads and teams, including formulation development, analytical development, material science, solid-state sciences, process engineering, and drug product manufacturing.
•Works closely with process development, manufacturing science and technology, external manufacturing partners, and commercial manufacturing organizations to integrate modeling into scale-up, technology transfer, process characterization, and manufacturing readiness.
•Collaborates with quality and regulatory stakeholders to establish scientifically justified approaches for model use in development decisions, process understanding, control strategy development, and regulatory documentation.
•Leads technical interactions with external modeling experts, engineering consultants, software providers, academic groups, equipment suppliers, and development and manufacturing partners.
•Supports external collaborations and contracting in partnership with procurement, legal, and relevant governance functions.
Innovation
•Evaluates and implements emerging modeling technologies, including mechanistic process models, computational material science approaches, powder flow and compaction models, process simulation, digital twins, and data-driven predictive tools where appropriate to pharmaceutical development.
•Advances predictive modeling to improve formulation selection, understand material and process variability, optimize process parameters, and reduce reliance on empirical trial-and-error development.
•Develops approaches t